Scientific Team

TheraVectys benefits from the experience of greatest specialist in Lentiviral vectors
which peer-reviewed papers have paved the way to gene therapy.

After working as a researcher in the field of vaccines and immunotherapy, Christian Bréchot was president and general manager of the largest scientific institutions in the field of health in France.
Dr. Brechot is currently the Senior Associate Dean for Research in Global Affairs and the Associate Vice-President for International Partnerships and Innovation at the University of South Florida, Tampa, USA.
Additionally, he is currently the President of the Global Virus Network, Baltimore, USA and was the former President of the Institut Pasteur, Paris, France.

Co-founder and Head of the preclical development at Vaxon Biotech, she led research and development projects for more than 20 years. She has extensive experience in tumour immunology and anti-tumour vaccination. Her in-depth knowledge covers the entire process, from experimental developments to clinical trials. She is an expert in moving experimental cancer vaccines into Phase I and II clinical trials. Jeanne Menez-Jamet has a university degree in microorganism genetics and a post doctoral experience at the Institut Gustave Roussy.